Leonard S SchleiferUS

Bd. Co-Chair, President & CEO, REGENERON PHARMACEUTICALS, INC. (REGN)

Net worth (est.)

$532.9M

#357 in the US

¥84.1B · US-listed shares

Dividends (a year)

CEO pay (a year)

$7.3M

Incl. stock awards

Latest filing

2025-12-31

Form 3/4/5 transaction date

Holdings

Company	Held by	Shares	Price	Value	Dividends
REGENERON PHARMACEUTICALS, INC. REGN · Bd. Co-Chair, President & CEO	By 2025 GRAT	300,000	$774.61	$232.4M	—
REGENERON PHARMACEUTICALS, INC. REGN · Bd. Co-Chair, President & CEO	Direct	214,523	$774.61	$166.2M	—
REGENERON PHARMACEUTICALS, INC. REGN · Bd. Co-Chair, President & CEO	By 2024 GRAT	127,484	$774.61	$98.8M	—
REGENERON PHARMACEUTICALS, INC. REGN · Bd. Co-Chair, President & CEO	By Trust	39,985	$774.61	$31.0M	—
REGENERON PHARMACEUTICALS, INC. REGN · Bd. Co-Chair, President & CEO	By 401(k) Plan	5,989	$774.61	$4.6M	—

Estimated from SEC Form 3/4/5 holdings and prices from SEC Fails-to-Deliver and Form 13F data. Options and RSUs excluded. Source: U.S. Securities and Exchange Commission (EDGAR). SEC filings